Actively Recruiting

Phase Not Applicable
Age: 7Years - 11Years
All Genders
NCT05420766

Impact of Sleep Duration on Immune Balance in Urban Children With Asthma

Led by Rhode Island Hospital · Updated on 2025-09-22

204

Participants Needed

1

Research Sites

219 weeks

Total Duration

On this page

Sponsors

R

Rhode Island Hospital

Lead Sponsor

B

Brown University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Urban children with asthma are at high risk for short sleep, due to an environment that jeopardizes both sleep and asthma management. Further, urban children with asthma suffer from altered immune balance, a key biological process contributing to individual differences in asthma morbidity and sleep health. In the proposed research, the researchers will examine the effects of shortened and recovery sleep on immune balance and associated changes in lung function in urban children with allergic asthma through an experimental design.

CONDITIONS

Official Title

Impact of Sleep Duration on Immune Balance in Urban Children With Asthma

Who Can Participate

Age: 7Years - 11Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged 7 to 11 years
  • Physician-diagnosed asthma confirmed by parent and pediatrician
  • Current persistent asthma with a prescription for an asthma controller medicine
  • Obtains 9.0 to 11.0 hours of sleep per 24-hour day in the past month
  • Positive allergy skin test performed at clinic visit
  • Lives and attends school in specified urban areas of Rhode Island or Massachusetts
  • Has a primary caregiver who speaks English
Not Eligible

You will not qualify if you...

  • No asthma diagnosis
  • No use of asthma controller medication
  • Severe persistent asthma that is poorly controlled
  • Additional pulmonary disease, medical conditions, or immune deficiency disorders
  • Use of systemic steroids within 30 days before screening
  • Asthma-related emergency department visit or hospitalization in past 90 days
  • Marked developmental delay, psychiatric, academic, behavioral problems, or learning disabilities
  • Tanner stage 3 to 5 of pubertal development
  • Diagnosed ADHD or use of stimulant medications for ADHD
  • Apnea-Hypoxia Index greater than 5 indicating sleep disordered breathing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rhode Island Hospital

Providence, Rhode Island, United States, 02903

Actively Recruiting

Loading map...

Research Team

D

Daphne Koinis-Mitchell, PhD

CONTACT

S

Sheryl J Kopel, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here